DE60219630D1 - Bicyclische pyrrolidinverbindungen - Google Patents
Bicyclische pyrrolidinverbindungenInfo
- Publication number
- DE60219630D1 DE60219630D1 DE60219630T DE60219630T DE60219630D1 DE 60219630 D1 DE60219630 D1 DE 60219630D1 DE 60219630 T DE60219630 T DE 60219630T DE 60219630 T DE60219630 T DE 60219630T DE 60219630 D1 DE60219630 D1 DE 60219630D1
- Authority
- DE
- Germany
- Prior art keywords
- bicyclic
- treatment
- 7alkanes
- pyrrolidin
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29841801P | 2001-06-15 | 2001-06-15 | |
US298418P | 2001-06-15 | ||
PCT/EP2002/006586 WO2002102791A1 (en) | 2001-06-15 | 2002-06-14 | Pyrrolidine bicyclic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60219630D1 true DE60219630D1 (de) | 2007-05-31 |
DE60219630T2 DE60219630T2 (de) | 2007-12-27 |
Family
ID=23150431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60219630T Expired - Lifetime DE60219630T2 (de) | 2001-06-15 | 2002-06-14 | Bicyclische pyrrolidinverbindungen |
Country Status (13)
Country | Link |
---|---|
US (3) | US6987104B2 (de) |
EP (1) | EP1406893B1 (de) |
JP (1) | JP4314340B2 (de) |
CN (1) | CN1512991A (de) |
AT (1) | ATE360014T1 (de) |
BR (1) | BR0210422A (de) |
CA (1) | CA2446931A1 (de) |
CY (1) | CY1107688T1 (de) |
DE (1) | DE60219630T2 (de) |
DK (1) | DK1406893T3 (de) |
ES (1) | ES2283589T3 (de) |
PT (1) | PT1406893E (de) |
WO (1) | WO2002102791A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE360014T1 (de) * | 2001-06-15 | 2007-05-15 | Vicuron Pharm Inc | Bicyclische pyrrolidinverbindungen |
JP2006503053A (ja) * | 2002-09-19 | 2006-01-26 | ノバルティス アクチエンゲゼルシャフト | 中間体の製造法 |
WO2004076053A2 (en) * | 2003-02-21 | 2004-09-10 | Novartis Ag | Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds |
GB0319917D0 (en) * | 2003-08-23 | 2003-09-24 | British Biotech Pharm | Metalloproteinase inhibitors |
DE602004032548D1 (de) * | 2003-08-23 | 2011-06-16 | Merck Serono Sa | Derivate von hydroxamsäure als metalloproteinaseinhibitoren |
EP1732907A1 (de) * | 2004-03-26 | 2006-12-20 | Arpida A/S | Peptid-deformylase-hemmer |
US7638513B2 (en) | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
PE20060426A1 (es) | 2004-06-02 | 2006-06-28 | Schering Corp | DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa |
US20080161249A1 (en) * | 2004-11-17 | 2008-07-03 | Smithkline Beecham Corporation | Use of Novel Antibacterial Compounds |
GT200600196A (es) * | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina | |
EP1957449A1 (de) * | 2005-12-01 | 2008-08-20 | Schering Corporation | Verbindungen zur behandlung von entzündungskrankheiten und mikrobiellen erkrankungen |
SG133452A1 (en) * | 2005-12-30 | 2007-07-30 | Novartis Ag | Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases |
US9187485B2 (en) | 2007-02-02 | 2015-11-17 | Baylor College Of Medicine | Methods and compositions for the treatment of cancer and related hyperproliferative disorders |
US9085566B2 (en) * | 2007-02-02 | 2015-07-21 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic and related disorders |
AU2009279949A1 (en) * | 2008-08-04 | 2010-02-11 | Merck Sharp & Dohme Corp. | Urea derivatives as antibacterial agents |
ES2930814T3 (es) | 2016-05-11 | 2022-12-22 | Guangdong Hebo Pharmaceutical Co Ltd | Inhibidor de péptido deformilasa de anillo espiro de tres miembros o anillo espiro de cinco miembros y uso del mismo como agente antitumoral |
CN117224534A (zh) | 2016-07-21 | 2023-12-15 | 联合利华知识产权控股有限公司 | 用于治疗皮肤损伤的内酰胺 |
CN109475525A (zh) * | 2016-07-21 | 2019-03-15 | 荷兰联合利华有限公司 | 4-(4-氯苯基)-5-亚甲基-吡咯-2-酮和5-亚甲基-4-(对甲苯基)吡咯-2-酮用于治疗革兰氏阴性细菌感染 |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4052511A (en) * | 1976-02-13 | 1977-10-04 | E. R. Squibb & Sons, Inc. | Carboxyacylproline derivatives |
US4320057A (en) * | 1980-06-23 | 1982-03-16 | American Home Products Corporation | Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones |
US4290952A (en) * | 1980-06-23 | 1981-09-22 | American Home Products Corporation | Aryl-1-mercaptoalkanoylproline and homoproline derivatives |
US4311705A (en) * | 1980-10-06 | 1982-01-19 | E. R. Squibb & Sons, Inc. | Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines |
US4303662A (en) * | 1980-11-24 | 1981-12-01 | E. R. Squibb & Sons, Inc. | Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds |
US4321383A (en) * | 1980-11-24 | 1982-03-23 | E. R. Squibb & Sons, Inc. | Heterobicyclo intermediates |
JPS6188884A (ja) * | 1984-10-04 | 1986-05-07 | Sankyo Co Ltd | エンケフアリナ−ゼb阻害物質およびその製法 |
US4599361A (en) * | 1985-09-10 | 1986-07-08 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
DK77487A (da) | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
FR2609289B1 (fr) | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
US5128346A (en) * | 1987-09-21 | 1992-07-07 | Abbott Laboratories | Derivatives of D-glutamic acid and D-aspartic acid |
EP0334244A3 (de) | 1988-03-25 | 1991-05-29 | The Procter & Gamble Company | Peptide-Antagonisten von Bradykinin |
GB8827305D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8827308D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8919251D0 (en) | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
GB8921326D0 (en) | 1989-09-21 | 1989-11-08 | Beecham Group Plc | Novel treatment |
US5268384A (en) * | 1990-11-21 | 1993-12-07 | Galardy Richard E | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
DE69108529T2 (de) | 1990-12-03 | 1995-11-30 | Celltech Therapeutics Ltd | Peptidylderivate. |
CA2058797A1 (en) | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
GB9102635D0 (en) | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
IT1245712B (it) * | 1991-04-09 | 1994-10-14 | Boehringer Mannheim Italia | Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree |
AU2228292A (en) | 1991-06-14 | 1993-01-12 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
US5256657A (en) * | 1991-08-19 | 1993-10-26 | Sterling Winthrop, Inc. | Succinamide derivative matrix-metalloprotease inhibitors |
JPH05125029A (ja) | 1991-11-06 | 1993-05-21 | Yamanouchi Pharmaceut Co Ltd | 新規なアミド化合物又はその塩 |
DE69230916T2 (de) * | 1991-11-08 | 2000-12-14 | Sankyo Co | Piperazin Derivate als Collagenase Inhibitoren |
DE69309047T2 (de) | 1992-04-07 | 1997-09-11 | British Biotech Pharm | Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren |
GB9211706D0 (en) | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
GB9211707D0 (en) | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
US5318964A (en) | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
GB9215665D0 (en) | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
CA2136108A1 (en) | 1993-03-18 | 1994-09-29 | Makoto Sakamoto | Carbostyril derivatives as matrix metalloproteinases inhibitors |
GB9308695D0 (en) | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
ES2134939T3 (es) | 1993-04-27 | 1999-10-16 | Celltech Therapeutics Ltd | Derivados de peptidilo como inhibidores de metaloproteinas. |
GB9501737D0 (en) * | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
GB9411598D0 (en) | 1994-06-09 | 1994-08-03 | Hoffmann La Roche | Hydroxamic acid derivatives |
GB9502858D0 (en) | 1995-02-14 | 1995-04-05 | British Biotech Pharm | Novel use of matrix metalloproteinase inhibitors |
GB9504084D0 (en) | 1995-03-01 | 1995-04-19 | British Biotech Pharm | Synthesis of carboxylic and hydroxamic acid derivatives |
US5876727A (en) * | 1995-03-31 | 1999-03-02 | Immulogic Pharmaceutical Corporation | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
FR2733750B1 (fr) * | 1995-05-03 | 1997-06-13 | Synthelabo | Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique |
DK0939632T3 (da) | 1996-02-23 | 2006-01-30 | Lilly Co Eli | Non-peptidyl vasopressin V1a antagonister |
TW448172B (en) * | 1996-03-08 | 2001-08-01 | Pharmacia & Upjohn Co Llc | Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
GB9613547D0 (en) | 1996-06-27 | 1996-08-28 | Pharmacia Spa | Matrix metalloproteinase inhibitors |
AUPO721997A0 (en) | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
EP0925289A1 (de) | 1997-07-10 | 1999-06-30 | PHARMACIA & UPJOHN S.p.A. | Matrix metalloproteinase inhibitoren |
KR100600518B1 (ko) | 1998-02-07 | 2006-07-13 | 브리티쉬 바이오테크 파마슈티칼스 리미티드 | 항균제 |
US6852752B2 (en) | 1999-12-17 | 2005-02-08 | Vicuron Pharmaceuticals Inc. | Urea compounds, compositions and methods of use and preparation |
AU2268401A (en) | 1999-12-17 | 2001-06-25 | Versicor Inc | Novel succinate compounds, compositions and methods of use and preparation |
US6797820B2 (en) | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
WO2002028829A2 (en) | 2000-09-25 | 2002-04-11 | Questcor Pharmaceuticals, Inc. | Peptide deformylase inhibitors |
ATE360014T1 (de) | 2001-06-15 | 2007-05-15 | Vicuron Pharm Inc | Bicyclische pyrrolidinverbindungen |
AR036053A1 (es) | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
JP2006503053A (ja) | 2002-09-19 | 2006-01-26 | ノバルティス アクチエンゲゼルシャフト | 中間体の製造法 |
WO2004076053A2 (en) | 2003-02-21 | 2004-09-10 | Novartis Ag | Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds |
TW200427458A (en) | 2003-04-02 | 2004-12-16 | Novartis Ag | Crystalline N-formyl hydroxylamine compounds |
BRPI0411921A (pt) | 2003-06-26 | 2006-08-15 | Novartis Ag | processo para preparar intermediários úteis para preparar determinadas hidroxilaminas de n-formila antibacterianas |
GT200600196A (es) | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina |
-
2002
- 2002-06-14 AT AT02762286T patent/ATE360014T1/de not_active IP Right Cessation
- 2002-06-14 WO PCT/EP2002/006586 patent/WO2002102791A1/en active IP Right Grant
- 2002-06-14 DK DK02762286T patent/DK1406893T3/da active
- 2002-06-14 DE DE60219630T patent/DE60219630T2/de not_active Expired - Lifetime
- 2002-06-14 EP EP02762286A patent/EP1406893B1/de not_active Expired - Lifetime
- 2002-06-14 CN CNA028109902A patent/CN1512991A/zh active Pending
- 2002-06-14 US US10/171,705 patent/US6987104B2/en not_active Expired - Fee Related
- 2002-06-14 PT PT02762286T patent/PT1406893E/pt unknown
- 2002-06-14 BR BR0210422-9A patent/BR0210422A/pt not_active IP Right Cessation
- 2002-06-14 CA CA002446931A patent/CA2446931A1/en not_active Abandoned
- 2002-06-14 JP JP2003506264A patent/JP4314340B2/ja not_active Expired - Fee Related
- 2002-06-14 ES ES02762286T patent/ES2283589T3/es not_active Expired - Lifetime
-
2005
- 2005-06-13 US US11/151,131 patent/US7612059B2/en not_active Expired - Fee Related
-
2007
- 2007-06-28 CY CY20071100856T patent/CY1107688T1/el unknown
-
2008
- 2008-12-03 US US12/327,245 patent/US20090149509A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090149509A1 (en) | 2009-06-11 |
JP2005501020A (ja) | 2005-01-13 |
CA2446931A1 (en) | 2002-12-27 |
CN1512991A (zh) | 2004-07-14 |
JP4314340B2 (ja) | 2009-08-12 |
US20030069223A1 (en) | 2003-04-10 |
CY1107688T1 (el) | 2013-04-18 |
WO2002102791A1 (en) | 2002-12-27 |
PT1406893E (pt) | 2007-07-12 |
ES2283589T3 (es) | 2007-11-01 |
BR0210422A (pt) | 2004-08-17 |
ATE360014T1 (de) | 2007-05-15 |
DK1406893T3 (da) | 2007-08-06 |
US20050277683A1 (en) | 2005-12-15 |
US6987104B2 (en) | 2006-01-17 |
DE60219630T2 (de) | 2007-12-27 |
EP1406893B1 (de) | 2007-04-18 |
EP1406893A1 (de) | 2004-04-14 |
US7612059B2 (en) | 2009-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107688T1 (el) | Δικυκλικες ενωσεις πυρρολιδινης | |
CY1116754T1 (el) | Παραγωγα νιτροκατεχολης ως αναστολεις της comt | |
ATE461923T1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
ME00572A (en) | Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | |
SE0202241D0 (sv) | Novel Compounds | |
EA200701467A1 (ru) | Пирролидиновые ингибиторы иап (ингибиторов апоптоза) | |
EA200501348A1 (ru) | Замещенные арильные и гетероарильные производные, используемые в качестве модуляторов метаболизма глюкозы и для профилактики и лечения связанных с ним расстройств | |
EA200601391A1 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
BR0116804A (pt) | Derivados fenìlicos | |
NO20074959L (no) | Substituerte pyridinderivater | |
DE50310516D1 (de) | Fredericamycin-derivate | |
DE602004019548D1 (de) | Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri) | |
DE60334536D1 (de) | Furylverbindungen | |
TW200630367A (en) | Substituted adenines and the uses thereof | |
NO20054361D0 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte | |
MY138619A (en) | N-formyl hydroxylamine compounds | |
BR0313634A (pt) | Derivados de benzimidazol | |
DE60333746D1 (de) | Thienylverbindungen | |
CY1110537T1 (el) | Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιας | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
CY1111432T1 (el) | Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5 | |
DK1362045T3 (da) | 2-Thio-substituerede imidazolderivater og deres anvendelse inden for farmacien | |
EA200701813A1 (ru) | Новые амидозамещенные 6-фенилфенантридины | |
ATE335739T1 (de) | Cak inhibitoren und deren verwendungen | |
WO2005080549A3 (de) | Trioxacarcine und deren verwendung gegen infektionskrankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
R082 | Change of representative |
Ref document number: 1406893 Country of ref document: EP Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN, DE |